Potential drugs for early Alzheimer's disease:Donanemab injection

VernacularTitle:治疗早期阿尔茨海默病的潜在药物:Donanemab注射液
Author: Quan WAN ; Guo-Zhu BAI
Keywords: Alzheimer's disease; donanemab injection; early symptoms
From: The Chinese Journal of Clinical Pharmacology 2024;40(9):1372-1374
CountryChina
Language:Chinese
Abstract: Donanemab is a novel anti-amyloid antibody medication that is primarily used to treat early-stage symptomatic Alzheimer's disease.Clinical investigations have demonstrated that it modulates issues with cognitive function and everyday functioning.Preclinical research has discovered that it reduces amyloid deposition in the hippocampus and cortical layers of the brain.To better comprehend cutting-edge novel medications,this article examines the latest research on donanemab.